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Abstract 
Liver involvement with acute myeloid leukemia (AML) is rarely reported. The majority of 
published cases suggest a cholestatic picture and obstructive jaundice at presentation. 
On the contrary, our patient presented with transaminitis without cholestasis. Elevated 
liver function tests persisted in our patient despite cholecystectomy; however, they 
normalized with chemotherapy administration, suggesting that AML was the causative 
effect of the hepatitis-like picture. Our review of the literature revealed that most 
reported cases of AML with liver involvement had short-lived remissions and an overall 
ominous prognosis. In our opinion, patients who have liver involvement with AML 
should be offered alternative investigational therapies with a low hepatic toxicity profile. 
 
Case Report 
A 66-year-old woman presented with a two-month history of progressive mid-thoracic back pain 
with anorexia and 10 pounds weight loss. Her exam was unrevealing. Laboratory work showed 
thrombocytopenia (63,000/μl), mild leukocytosis (12,400/μl), and mild transaminitis (AST and ALT 
were 49 and 73 U/L respectively). Hepatitis serology was negative. Review of the peripheral smear 
showed few circulating blasts. A bone marrow biopsy and aspirate confirmed acute myeloid leukemia 
(AML) with complex karyotype (deletions of chromosomes 1p, 11q and 19p along with t(8;11) 
translocation). 
The patient developed worsening abdominal pain with rising AST and ALT. Abdominal magnetic 
resonance imaging (MRI) revealed an 11 mm T2 hyperintense lesion in the posterior dome of the liver 
with questionable stone in the neck of the gallbladder (fig. 1). Additional findings were suggestive of 
acute cholycystitis. While the patient underwent cholecystectomy, an intraoperative liver biopsy was 
performed showing hepatic infiltration with AML (fig. 2). Further studies confirmed that she had AML 
M0 based on the French-American-British (FAB) classification.  
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The patient was treated with two induction therapy programs (classic 7 + 3 regimen then high-dose 
cytarabine) that finally rendered her in complete remission (CR). However, this was short-lived lasting 
only 8 weeks, at which point her AML recurred with hepatic infiltration. At the time of recurrence, she 
demonstrated worsening performance status (Eastern Cooperative Oncology Group: 3) and 
deconditioning with multiorgan failure justifying enrolling her in a palliative care and a hospice 
program. The patient died shortly thereafter. 
Discussion 
Liver involvement with AML is rarely reported. The majority of published cases 
suggest a cholestatic picture and obstructive jaundice at presentation [1–3]. On the 
contrary, our patient presented with transaminitis without cholestasis. Elevated liver 
function tests persisted in our patient despite cholecystectomy, however, they normalized 
with chemotherapy administration suggesting that AML was the causative effect of the 
hepatitis-like picture. While most reported cases suggested myelomonocytic leukemia 
with or without atypical eosinophils as the most commonly described AML with liver 
involvement [2], one other report identified a patient with AML M0 as having leukemic 
liver disease [3]. 
Reported cases are in line with our experience in this patient. Patients are usually 
treated with traditional AML-type programs that combine cytarabine with anthracyclines, 
however, remissions are short-lived and the overall prognosis is ominous. Only two case 
reports suggested favorable results. One case had inv (16) genomic aberration while the 
other had normal karyotype [1, 4]. All other reports confirm the short time from 
diagnosis until death. 
Our case differs from other published reports in the literature in that our patient was 
older than most reported cases, presented with transaminitis as opposed to cholestasis, 
and had a subtype (AML M0) that is infrequently described in this setting. Unfortunately, 
our patient had the expected unfavorable outcome that others have described. In our 
opinion, patients who have liver involvement with AML should be offered alternative 
investigational therapies that have a low hepatic toxicity profile. 
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Fig. 1. MRI abdomen with 11 mm nonspecific T2 hyperintense lesion in the posterior dome of the 
liver (arrow). Hepatosplenomegaly with smooth liver edges measuring 23 cm superior to inferior and 
the spleen 12.5 cm near the upper limit of normal. No changes suggestive of cirrhosis or fatty 
infiltration. 
 
 
 
Fig. 2. Leukemic myeloblasts infiltrating hepatic sinusoids (arrow). 
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